UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Fiscal Year Ended March 31, 2025. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 001-32830 IGC PHARMA, INC. (Exact Name of Registrant as Specified in Its Charter) | Maryland | 20-2760393 | | --- | --- | | (State or other jurisdiction | ( ...